Evaluation of Different Psychiatric Symptoms in Patients With Thyroid Dysfunction

NCT ID: NCT06185309

Last Updated: 2023-12-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

85 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-01-01

Study Completion Date

2025-02-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

1. Evaluate psychiatric symptoms in patients with thyroid dysfunction.
2. Investigate effect of treatment on psychiatric symptoms after 2 months.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Thyroid dysfunction is associated with psychiatric symptoms in addition to endocrinal manifestations.

The study aims to evaluate the prevalence of psychiatric symptoms in patients with thyroid dysfunction and investigate the response after thyroid treatment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anxiety Depression Thyroid Dysfunction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients newly diagnosed as having thyroid dysfunction.

Exclusion Criteria

* Patients with other endocrinological disorders or significant medical or neurological diseases.
* Alcohol or substance abuse
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ahmed EmadElden Mohamed

Doctor resident

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Romany Hosny Gabra Henein, professor

Role: STUDY_DIRECTOR

Assiut University

Khaled Ahmed Mohamed, Professor

Role: STUDY_DIRECTOR

Assiut University

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ahmed EamdElden Mohamed Abdelhafez, MBCCH

Role: CONTACT

Phone: +201000316881

Email: [email protected]

Kerolos Hana, MBCCH

Role: CONTACT

Phone: +201140623624

Email: [email protected]

References

Explore related publications, articles, or registry entries linked to this study.

Aslan S, Ersoy R, Kuruoglu AC, Karakoc A, Cakir N. Psychiatric symptoms and diagnoses in thyroid disorders: a cross-sectional study. Int J Psychiatry Clin Pract. 2005;9(3):187-92. doi: 10.1080/13651500510029129.

Reference Type RESULT
PMID: 24937789 (View on PubMed)

Gulseren S, Gulseren L, Hekimsoy Z, Cetinay P, Ozen C, Tokatlioglu B. Depression, anxiety, health-related quality of life, and disability in patients with overt and subclinical thyroid dysfunction. Arch Med Res. 2006 Jan;37(1):133-9. doi: 10.1016/j.arcmed.2005.05.008.

Reference Type RESULT
PMID: 16314199 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

https://ejim.springeropen.com/articles/10.4103/ejim.ejim_22_19

Prevalence, risks, and comorbidity of thyroid dysfunction: a cross-sectional epidemiological study

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Psychiatry & thryoid disorders

Identifier Type: -

Identifier Source: org_study_id